Vice President of Clinical Effectiveness and Care Redesign
& Medical Director, Seton Health Alliance
Dr. Tate Erlinger rejoined Ascension Seton in February 2010 as Vice President of Clinical Effectiveness and Care Redesign within the Center for Experience and Effectiveness. He serves as the Medical Director for Seton Health Alliance.
He is responsible for providing physician leadership to clinical effectiveness and value creation opportunity projects Ascension Seton is embarking upon. These projects seek to improve value by providing the best care at the most appropriate cost utilizing evidence-based practice and standardized clinical care paths where appropriate.
He received his undergraduate degree from University of Texas at Austin and his M.D. from the University of Texas Health Science Center at San Antonio. He completed his residency in Internal Medicine at the University of Chicago. He completed a three-year clinical research fellowship at Johns Hopkins School of Medicine and his Masters in Public health at the Johns Hopkins Bloomberg School of Public Health.
He remained on the Johns Hopkins faculty for an additional five years conducting research in cardiovascular disease, lifestyle modification and conducting population-based analyses of chronic disease. He returned to Texas in 2005 and began working with Ascension Seton on Clinical Research and quality initiatives.
In 2010, after conducting some novel work during the H1N1 outbreak at Ascension Seton, he went on to become the State Epidemiologist for Texas. In that role, he spearheaded new initiatives in public health involving health care quality, quality improvement and health information technology policy while overseeing statewide epidemiology activities. Before rejoining Ascension Seton, he was the Chief Analytics Officer and Vice President for Quality Improvement for a Texas-based health plan where he initiated clinical analytics and oversaw Quality Improvement activities and performance improvement initiatives.